To demonstrate the importance of TG2 crosslinking activity in cardiac fibrosis and to validate TG2 as a potential therapeutic target, we first looked at a progressive diffuse model of cardiac fibrosis, where hypertension was induced by chronic infusion of angiotensin II (AngII), which provides an example of reactive fibrosis. This evidence concerns the gene AGT and hypertensive disorder.